Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
microfluidic devices. The position will follow the guidelines outlined below. For more details about our group, please refer to the following webpage. https://www.oist.jp/research/buribushi/yokoyama [Work
-
(https://oni.bio/ ). The group is located in the new Kavli Institute for Nanoscience Discovery (https://kavlinano.ox.ac.uk/ ), a vibrant environment for interdisciplinary research at the interface
-
for synthesis. A postdoctoral position is available for 3-years to work with Professor Florian Hollfelder at the Biochemistry Department of Cambridge University (https://hollfelder.bioc.cam.ac.uk/ ). The project
-
and guidance system for these micro-swimmers, interacting with real-time optical visualization in a microfluidic network. • Study of the fidelity of the movement of micro-swimmers to the set trajectory
-
, bioscience, molecular biology or a related field. Candidates should have extensive experience of working with microfluidic chips, mammalian cell culture and advanced imaging techniques. More information on our
-
generated FUS-eGFP reporter iPSCs for live-cell imaging of RNP granules, facilitating compound screening to identify novel drugs for repurposing as ALS therapeutics. We also generated a microfluidic device
-
The University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
organize data as a member of a multidisciplinary biomedical engineering team. This role will involve the generation and maintenance of cells for immune-competent microfluidic organs-on-chip and will involve
-
characteristics. In vitro microfluidic models will use disease-specific flow conditions and blood samples from DVT patients. Your work will ultimately contribute to a risk prediction tool for recurrent DVT and PTS
-
in hemodialysis patients. Your work will involve: Developing in silico models using computational fluid dynamics combined with macroscopic thrombus formation modelling. Creating in vitro microfluidic
-
duration of 3 years, starting in Summer 2026. Objective of the project: Finnadvance is an organ-on-chip company that has developed the AKITA microfluidic platform. It elicits the generation of biological